Analysis of glutathione S-transferase genes polymorphisms and the risk of schizophrenia in a sample of Iranian population

Neuron Glia Biology

Volumn 7, Issue 2-4, 2011, Pages 199-203

  Kashani, Farah Lotfi ^a   Kordi Tamandani, Dor Mohammad ^b   Sahranavard, Roya ^b   Hashemi, Mohammad ^c   Kordi Tamandani, Farzaneh ^d   Torkamanzehi, Adam ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

GSTM; GSTP; GSTT; Polymorphism; Schizophrenia

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84871292037     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X12000130     Document Type: Article

References (30)

1. Acar H., Kilinc M., Guven S. and Inan Z. (2011) Glutathione S-transferase M1 and T1 polymorphisms in Turkish patients with varicocele. Andrologia 44, 34-37; doi: i10.1111/j.1439-0272.2010.01103.x.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
3. Behrens M.M. and Sejnowski T.J. (2009) Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 57, 193-200; doi: iS0028-3908(09)00157-9 [pii] 10.1016/j.neuropharm.2009.06.002.
4. Benes F.M., Matzilevich D., Burke R.E. and Walsh J. (2006) The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry 11, 241-251.
5. Berk M., Ng F., Dean O., Dodd S. and Bush A.I. (2008) Glutathione: a novel treatment target in psychiatry. Trends in Pharmacological Sciences 29, 346-351.
6. Bjork K., Saarikoski S.T., Arlinde C., Kovanen L., Osei-Hyiaman D., Ubaldi M. et al. (2006) Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity. FASEB Journal 20, 1826-1835; doi: i20/11/1826 [pii] 10.1096/fj.06-5896com.
7. Csejtei A., Tibold A., Varga Z., Koltai K., Ember A., Orsos Z. et al. (2008) GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Research 28, 1917-1922.
8. Gravina P., Spoletini I., Masini S., Valentini A., Vanni D., Paladini E. et al. (2011) Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia. Psychiatry Research 187, 454-456.
9. Gysin R., Kraftsik R., Sandell J., Bovet P., Chappuis C., Conus P. et al. (2007a) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proceedings of the National Academy of Sciences of the U.S.A. 104, 16621-16626.
10. Harada S., Tachikawa H. and Kawanishi Y. (2001) Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochemical and Biophysical Research Communications 281, 267-271.
11. Hebbring S.J., Adjei A.A., Baer J.L., Jenkins G.D., Zhang J., Cunningham J.M. et al. (2007) Human SULT1A1 gene: copy number differences and functional implications. Human Molecular Genetics 16, 463-470.
12. Koizumi H., Hashimoto K., Kumakiri C., Shimizu E., Sekine Y., Ozaki N. et al. (2004) Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 126B, 43-45.
13. Kordi-Tamandani D.M., Hashemi M., Birjandian E., Bahari A., Valizadeh J. and Torkamanzehi A. (2011a) Lack of association of GSTT1 and GSTP1 genes methylation and their expression profiles with risk of NAFLD in a sample of Iranian patients. Clinics and Research in Hepatology and Gastroenterology 35, 387-392.
14. Kordi-Tamandani D.M., Hashemi M., Sharifi N., Kaykhaei M.A. and Torkamanzehi A. (2011b) Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Molecular Biology Reports 39, 937-943; doi: i10.1007/s11033-011-0819-x.
15. Martin N.J., Collier A.C., Bowen L.D., Pritsos K.L., Goodrich G.G., Arger K. et al. (2009) Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutation Research 674, 93-100; doi: iS1383-5718(08)00278-7 [pii] 10.1016/j.mrgentox.2008. 09.009.
16. Masoudi M., Saadat I., Omidvari S. and Saadat M. (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Molecular Biology Reports 36, 781-784; doi: i10.1007/s11033-008-9245-0.
17. Mishra A., Chandra R., Mehrotra P.K., Bajpai P. and Agrawal D. (2011) Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients. Surgery Today 41, 471-476; doi: i10.1007/s00595-009-4310-4.
18. Mohammadynejad P., Saadat I., Ghanizadeh A. and Saadat M. (2011) Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1). Psychiatry Research 186, 144-146.
19. Pae C.-U., Kim J.-J., Lee S.-J., Lee C.-U., Lee C., Paik I.-H. et al. (2003) Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 519-523.
20. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M. et al. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical Journal 300, 271-276.
21. Rocha A.V., Talbot T., Magalhaes da Silva T., Almeida M.C., Menezes C.A., Di Pietro G. et al. (2011) Is the GSTM1 null polymorphism a risk factor in primary open angle glaucoma? Molecular Vision 17, 1679-1686.
22. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M. and Coyle J.T. (2006) Neurobiology of schizophrenia. Neuron 52, 139-153; doi: iS0896-6273(06)00722-7 [pii] 10.1016/j.neuron.2006.09.015.
23. Saadat M., Mobayen F. and Farrashbandi H. (2007) Genetic polymorphismof glutathione S-transferase T1: a candidate geneticmodifier of individual susceptibility to schizophrenia. Psychiatry Research 153, 87-91; doi: iS0165-1781(06)00100-4 [pii] 10.1016/j.psychres.2006.03.024.
24. Sharp A.J., Cheng Z. and Eichler E.E. (2006) Structural variation of the human genome. Annual Review of Genomics and Human Genetics 7, 407-442.
25. Simic T., Savic-Radojevic A., Pljesa-Ercegovac M., Matic M. and Mimic-Oka J. (2009) Glutathione S-transferases in kidney and urinary bladder tumors. Nature Reviews. Urology 6, 281-289; doi: inrurol.2009.49 [pii] 10.1038/nrurol.2009.49.
26. Singh N., Sinha N., Kumar S., Pandey C.M. and Agrawal S. (2011) Glutathione S-transferase gene polymorphism as a susceptibility factor for acute myocardial infarction and smoking in the North Indian population. Cardiology 118, 16-21.
27. Smythies J. (1999) Redox mechanisms at the glutamate synapse and their significance: a review. European Journal of Pharmacology 370, 1-7.
28. Sullivan P.F., Kendler K.S. and Neale M.C. (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 1187-1192.
29. TosicM., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F. et al. (2006) Schizophrenia and oxidative stress: glutamate cysteine ligasemodifier as a susceptibility gene. American Journal of Human Genetics 79, 586-592; doi: iS0002-9297(07)62760-8 [pii] 10.1086/507566.
30. Zeevalk G.D., Manzino L., Sonsalla P.K. and Bernard L.P. (2007) Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease. Experimental Neurology 203, 512- 520; doi: S0014-4886(06)00540-1 [pii] 10.1016/j.expneurol.2006.09.004.